6-K

REPORT OF FOREIGN PRIVATE ISSUER

Company: Altamira Therapeutics Ltd.
Filed: June 5, 2020
Period of Report: June 5, 2020
Accession Number: 0001213900-20-014233

View Document ↗ View on SEC.gov ↗